Parsec Financial Management’s Abiomed Inc ABMD Stock Holding History

Parsec Financial Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-710	Closed	-$235K	–	308
2022 Q1	$235K	Hold	710	–	–	0.01%	277
2021 Q4	$255K	Hold	710	–	–	0.01%	264
2021 Q3	$264K	Hold	710	–	–	0.01%	253
2021 Q2	$222K	Hold	710	–	–	0.01%	254
2021 Q1	$226K	Hold	710	–	–	0.01%	244
2020 Q4	$230K	Buy	+710	New	+$196K	0.01%	236
2019 Q3	–	Sell	-788	Closed	-$205K	–	253
2019 Q2	$205K	Hold	788	–	–	0.01%	226
2019 Q1	$225K	Hold	788	–	–	0.01%	218
2018 Q4	$256K	Hold	788	–	–	0.02%	207
2018 Q3	$354K	Buy	788 +78	+11%	+$30.7K	0.02%	196
2018 Q2	$290K	Hold	710	–	–	0.02%	202
2018 Q1	$207K	Buy	+710	New	+$180K	0.01%	217

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parsec Financial Management's ABMD Position: Q2 2022 in Review

Parsec Financial Management sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 710 shares — an estimated $235K sold.

Parsec Financial Management first reported a position in ABMD in Q1 2018 and held it in 12 quarters. The position peaked at $354K in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

Parsec Financial Management reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
Parsec Financial Management sold 710 Abiomed Inc shares in Q2 2022, an estimated $235K.
Parsec Financial Management first reported a position in Abiomed Inc in Q1 2018 and held it in 12 quarters.
Parsec Financial Management's Abiomed Inc position peaked at $354K in Q3 2018.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Parsec Financial Management's 13F filing for Q2 2022, filed 6 Jul 2022.